HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 282.94 billion as of December 5, 2025. Its market cap has decreased by -61.59% in one year.

Market Cap

282.94B

Enterprise Value

301.67B

Revenue

63.25B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,370.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 282.94B, an increase of 167.41%. That is a compound annual growth rate of 6.46%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	282.94B	-69.72%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.96T
Celltrion	40.11T
ALTEOGEN	24.41T
ABL Bio	10.51T
SK Biopharmaceuticals	10.49T
Yuhan	8,755.13B
LigaChem Biosciences	6,753.15B
Peptron	6,645.44B

Market Cap Rankings